LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys. To determine whether this characteristic heightens bleeding risk in ...

Chicago, IL - Almost half of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) who received enoxaparin (Lovenox, Sanofi-Aventis) were given doses that were either higher or lower than ...

Sanofi-Aventis is suing FDA, claiming the agency acted inconsistently and unlawfully in approving a generic version of its anticoagulant Lovenox. The approval of the generic, developed by Momenta ...

LONDON, July 8 (Reuters) - Bayer AG's experimental pill rivaroxaban is significantly more effective than standard injections of Lovenox in preventing blood clots after knee surgery, researchers said ...

Well, we sort of figured this was coming. Sanofi-Aventis has gone to court here in Washington to prevent rival drugmaker Novartis from selling a generic version of the blockbuster blood-thinner ...

WASHINGTON—A federal judge held off a decision on whether to bar a generic version of Sanofi-Aventis SA's big-selling drug Lovenox, in a lengthy court hearing Tuesday that highlighted the stakes for a ...